Abstract
IntroductionSpontaneous retroperitoneal bleeding is a rare but potentially life-threatening event of varied etiology. Herein we report a case of bilateral non-traumatic retroperitoneal hemorrhage.Case presentationA 50-year-old Greek man, who was on a non-steroidal anti-inflammatory agent (nimesulide) for ankylosing spondylitis, presented with a right retroperitoneal hematoma combined with contralateral subcapsular renal hematoma. Bleeding on his right side was successfully controlled by arterial embolization with coils, whereas the left renal hematoma was treated conservatively. His recovery period was uneventful.ConclusionThis is the first reported case of bilateral retroperitoneal bleeding in a patient receiving nimesulide for ankylosing spondylitis. The application of minimally invasive techniques resulted in the desired positive outcome with preservation of both renal units.
Highlights
Spontaneous retroperitoneal bleeding is a rare but potentially life-threatening event of varied etiology
This is the first reported case of bilateral retroperitoneal bleeding in a patient receiving nimesulide for ankylosing spondylitis
The application of minimally invasive techniques resulted in the desired positive outcome with preservation of both renal units
Summary
To the best of the authors’ knowledge, this is the first reported case of bilateral spontaneous retroperitoneal hemorrhage in a patient on nimesulide for ankylosing spondylitis. Diagnosis and prompt treatment are the mainstays of successful management of this rare untoward event. This case emphasizes the role of minimally invasive techniques, such as arterial embolization, in achieving a positive outcome. Consent Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. Authors’ contributions ICM and EC were the major contributors in writing the manuscript. AS and GA collected the data and helped in drafting the manuscript. All authors read and approved the final manuscript. Competing interests The authors declare that they have no competing interests
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have